David A. Siegel Alector, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Alector, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 479,700 shares of ALEC stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
479,700
Previous 539,500
11.08%
Holding current value
$2.91 Million
Previous $3.25 Million
32.95%
% of portfolio
0.0%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ALEC
# of Institutions
165Shares Held
59MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$55.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$32.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$28.1 Million0.69% of portfolio
-
Morgan Stanley New York, NY3.01MShares$18.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.79MShares$16.9 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $500M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...